Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1987.59 (Glytoucan)

Id:f534fd76-08fa-5cb1-a1f6-e1958b502ed9

Glytoucan:G05496GH

Results found

Linked to

	Label	Description
	1987.59 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1987.59 has canonical residue n-glycan core b-d-glcpnac b Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1987.59 has canonical residue n-glycan a-d-manp 4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1987.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G90805EM-GLYCOSEQ00165427 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1987.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G82879RY-GLYCOSEQ00081512 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1987.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G50531NJ-GLYCOSEQ00195788 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1987.59 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1987.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G05496GH-GLYCOSEQ00201213 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1987.59 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000027 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1987.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G96639QR-GLYCOSEQ00010615 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1987.59 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1987.59 has canonical residue n-glycan core b-d-glcpnac b

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1987.59 has canonical residue n-glycan a-d-manp 4

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1987.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G90805EM-GLYCOSEQ00165427 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1987.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G82879RY-GLYCOSEQ00081512 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1987.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G50531NJ-GLYCOSEQ00195788 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1987.59 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1987.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G05496GH-GLYCOSEQ00201213 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1987.59 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000027 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1987.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G96639QR-GLYCOSEQ00010615 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.